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The protozoa Trypanosoma cruzi, the aetiological agent of Chagas disease, belongs to the Trypanosomatidae 
family that presents as a main characteristic a single mitochondrion with an enlarged portion termed 
kinetoplast. This structure contains the mitochondrial DNA (kDNA) that is composed of interlocked maxi and 
minicircles that are released from this network for replication. Since the kDNA arrangement is unique in 
nature and represents a hallmark of kinetoplastids, it constitutes a valuable target in chemotherapeutic and cell 
biology studies. In this work, we analyzed the effects of berenil, a minor-groove binding agent that targets 
preferentially the kDNA, on the proliferation and ultrastructure of T. cruzi, using different microscopy 
approaches. For this purpose, cells were cultivated in medium containing different drug concentrations (2, 10, 
20 and 50 µM) and samples were collected after each 24 hours for counting on Neubauer’s chamber and for 
analysis by optical and electron microscopy. The presence of dyskinetoplastic cells, which lost partially or 
totally the kDNA, was revealed after DAPI staining and cell viability was verified using MTS/PMS method 
based on mitochondrial viability. Our results showed that berenil promoted a slight effect on parasite growth 
and its viability was not affected. However, this compound caused significant changes at ultrastructural level 
as revealed by transmission electron microscopy, when comparing control and treated cells, such as 
mitochondrial swelling, including loss of matrix, and strong changes on kDNA arrangement. Furthermore, 
membrane profiles were observed in the middle of the kinetoplast network, as well as an electron-lucid area 
close to the kDNA. In order to investigate if such areas corresponded to uncatenated minicircles, we used the 
TdT technique that specifically recognizes DNA, however no labeling was detected in this kinetoplast region. 
Using atomic force microscopy, we observed that the isolated kDNA presented a more compact arrangement 
after berenil treatment, when compared to control cells. Taking our results together we can assume that 
berenil impeaches the minicircle decatenation of the network, thus impairing DNA replication and 
culminating in the appearance of dyskinetoplastic cells. Since berenil affected directly the kDNA topology, 
our data reinforce the idea that the kinetoplast represents a potential target for chemotherapy against 
trypanosomatids. 
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 Fig. 1: Figure 1: Non-treated Trypanosoma cruzi, 
showing the bar shape kinetoplast, the nucleus and the 
mitochondrion. n = nucleus, ht = heterochromatin, m = 
mitochondrion, k = kinetoplast, f = flagellum, gc = 
Golgi complex, cy = cytostome. 
 
Fig. 2: Figure 2: Transmission electron microscopy 
of parasite treated with 20 µM berenil for 48 hours. 
Note the electron-lucid area close to the kDNA 
network (arrowhead). 
 
Fig. 3: Figure 3: TdT technique applied on parasite 
treated with 20 µM berenil for 48 hours. Gold particles 
were observed in the compact kDNA, but not at the 
kinetoplast electron-lucid area (arrowhead). 
 
Fig. 4: Figure 4: Atomic force microscopy of the 
kDNA after treatment with 50 µM berenil for 72 
hours. Note that the network periphery is more 
compact (white arrow). 
 
